Cipla pharma to establish US HQ in Warren

Cipla pharma to establish US HQ in Warren

10 Independence Place, Warren. – (JLL) Mumbai, India-based Cipla Inc. pharmaceuticals will establish a U.S. headquarters at Independence Place in Warren.  JLL represented building owner American Equity Partners LLC. Cipla signed a long-term lease for 14,280 square feet of Class A office space. The 120,528-square-foot property is located inside the 118-acre Somerset Hills Corporate Center. […]

FSD Pharma Inc. Announces Appointment of Chief Commercial Officer

FSD Pharma Inc. Announces Appointment of Chief Commercial Officer

TORONTO, June 21, 2018 /CNW/ – Thomas Fairfull, President and Chief Executive Officer of FSD Pharma Inc. (“FSD” or the “Company”) (CSE:HUGE), is pleased to announce the appointment of Mr. Michael Ash as the Chief Commercial Officer of FV Pharma Inc. (“FV Pharma”), a wholly-owned subsidiary of the Company. Michael Ash brings a wealth of […]

MNX Logistics to build a cool-chain pharma facility at JFK

MNX Logistics to build a cool-chain pharma facility at JFK

Long Beach-based MNX Global Logistics has opened a 14,000-square-foot “healthcare and life sciences” logistics facility near New York’s JFK International Airport for temperature-sensitive pharmaceutical cargo, in compliance with the Good Distribution Practice (GDP) standards for the safe transportation of cool-chain products. The company’s CEO, Paul Martins, cites a heightened demand for […]

Unichem Pharma Announces Executive Leadership Change

Unichem Pharma Announces Executive Leadership Change

Mr. Delaney is an accomplished leader with over 24 years of experience in brand and generic pharmaceutical management.  He brings deep expertise in many areas of generic pharmaceutical management, including sales, marketing, contract negotiation, business development, manufacturing/distribution, third party payor management, product portfolio selection and product life cycle management.  Mr. Delaney has worked with outstanding […]

Whistleblower: Purdue Pharma Continued Shady Sales Tactics for OxyContin

Whistleblower: Purdue Pharma Continued Shady Sales Tactics for OxyContin

Purdue Pharma, which makes the opioid OxyContin, continued deceptive sales tactics after settling a Department of Justice lawsuit for over $630 million in 2007, a former employee said. Carol Panara told CBS News that during her 2008 sales training, she was told to tell doctors that someone in pain could experience addiction-like symptoms known as […]

Purdue Pharma lays off 350, cutting remainder of sales force

Purdue Pharma lays off 350, cutting remainder of sales force

Dive Brief: Purdue Pharma this week laid off about 350 employees, including the remainder of its sales force, as it attempts to move away from a business model built around the aggressive marketing of prescription opioids like its top-selling Oxycontin. The company, which remains in the spotlight for its alleged hand in contributing to an […]

Purdue Pharma Battling More States Over Opioid Crisis

Purdue Pharma Battling More States Over Opioid Crisis

Oxycontin maker Purdue Pharma has been in the hot seat when it comes to the opioid crisis, as some feel that the company deceptively marketed its prescription painkiller to generate sales, which led in part to the current opioid crisis. Lawsuits had been filed by sixteen states and Puerto Rico. In mid-May 2018, six additional […]

Five things for pharma marketers to know: Thursday, June 21, 2018

Five things for pharma marketers to know: Thursday, June 21, 2018

Copyright © 2018 Haymarket Media, Inc. All Rights Reserved This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media’s Privacy Policy and Terms & Conditions. Source link

Purdue Pharma used deceptive sales tactic for OxyContin after settlement, ex-sales rep says

Purdue Pharma used deceptive sales tactic for OxyContin after settlement, ex-sales rep says

Purdue Pharma laid off its entire sales team this week. Now only on “CBS This Morning,” a former Purdue sales representative reveals the drugmaker downplayed the dangers of opioids, even after pleading guilty to a felony charge of “misbranding.” Purdue’s 2007 settlement with the Justice Department included more than $630 million in fines.  But 24 […]

1 2 3 112